“…Recently, there has been a growing interest in developing phytopharmaceuticals from medicinal plants to cope with this condition, owing to their non-addictive and non-toxic nature. Some plant products have been found to be more effective in the management of MI throught augmentation of myocardial antixoidants, such as Danshensu (Tang et al, 2011), Rhodobryum roseum extract (Hu et al, 2009), Cladosiphon okamuranus fucoidan (Thomes et al, 2010), 20(S)-panaxadiol (Wang, Meng, Zhang, Bi, & Jiang, 2010), and so on. Salvia miltiorrhiza, commonly known as DanShen, is one of the most famous traditional Chinese herbal medicines used for the treatment of ischemic cardiovascular diseases, containing phenolic compounds and potent antioxidant moieties (Ji, Tan, Zhu, Linz, & Zhu, 2003;Ji et al, 2004;Sun et al, 2005).…”